Clinical Trial Update: Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma [Phase 2]

View source ↗

Summary

Clinical trial update for tandem high-dose chemotherapy with 131I-MIBG treatment in high-risk neuroblastoma (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)

Snippet

Sponsor: Samsung Medical Center | Conditions: High Risk Neuroblastoma | Phase 2 | Status: UNKNOWN